Catalyst Wire Dossier Catalyst Wire Dossier

Travoprost Intracameral Implant (Second Generation)

travoprost · Glaukos Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Travoprost Intracameral Implant (Second Generation), covering 2026-03-02 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant [Phase 3]

See pricing